PTC Therapeutics Inc (STU:BH3)
€ 67.16 -1.7 (-2.47%) Market Cap: 5.60 Bil Enterprise Value: 4.29 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 56/100

PTC Therapeutics Inc at Barclays Global Healthcare Conference Transcript

Mar 10, 2020 / 03:45PM GMT
Release Date Price: €41.4 (-6.33%)
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

Hi, everyone. My name is Gena Wang. I'm SMID cap biotech analyst at the Barclays. In this special situation, I first wish everyone, stay healthy, and I would like to thank all the participants, including investors, companies and especially our event team and our corporate access team who made this virtual health care conference possible.

With that, I would like to introduce our next speakers, Marcio Souza, Chief Operating Officer; Alex Kane, Executive Director of Investor Relations from PTC.

Marcio, I will hand over to you.

Marcio Silva De;Souza
PTC Therapeutics, Inc. - COO

' -

Hey, Gena, and hey, everyone, and thanks. I'm going to echo what Gena just said. I hope everyone is safe and will remain safe throughout this challenging situation we're having globally. Very glad for Barclays to organize this and to keep the conference running. And I think we're all a little bit of apologetic. I'm sorry for not being able to be face-to-face with most of you down in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot